This Medical Research Future Fund - Emerging Priorities and Consumer Driven Research Initiative – 2019 Mental Health Pharmacogenomics Grant Opportunity will support research that addresses a gap in evidence related to the application of pharmacogenomics for neuropsychiatric conditions.
The objectives of the 2019 Mental Health Pharmacogenomics Grant Opportunity are to:
- reduce barriers to clinical uptake of pharmacogenomics testing for patients presenting with neuropsychiatric conditions
- address gaps in evidence related to the application of pharmacogenomics for neuropsychiatric conditions
- encourage research that combines new or existing technologies with large-scale data, machine learning, clinical information, or patient biomarkers to develop new or refine existing tests that facilitate improved personalisation and efficacy of psychotropic medication regimens.
This grant opportunity is being administered by NHMRC on behalf of the Commonwealth Department of Health.
Further information on the Medical Research Future Fund and the Emerging Priorities and Consumer Driven Research Initiative is available on the Department’s website at: https://www.health.gov.au/mrff.